The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration. (posted Aug. 21, 2013)
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Why I Advocate for Arthritis: A Patient’s Perspective
Reverend Anthony J. Hillelson, who has rheumatoid arthritis, on why he lobbies Congress to support rheumatic disease research funding
Healthcare Providers Must Get Compliant with HIPAA Privacy Practices
Failure to have an updated Notice of Privacy Practices by September 23, 2013 could result in fines and penalties
New Methodology to Improve Cartilage Repair
A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)
B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)
Congress Considers More Regulation for Manufacturers of Compounding Drugs
New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)
President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?
What rheumatologists should know about complying with the PPSA when it goes into effect on August 1
How Rheumatologists Can Connect with Congress during August Recess
Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices
Rheumatology Drug Research Should Focus on Particular Groups of Patients
An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment
California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
- « Previous Page
- 1
- …
- 189
- 190
- 191
- 192
- 193
- …
- 249
- Next Page »
